Literature DB >> 9420296

Respiratory syncytial virus infection of neonatal monocytes stimulates synthesis of interferon regulatory factor 1 and interleukin-1beta (IL-1beta)-converting enzyme and secretion of IL-1beta.

R Takeuchi1, H Tsutsumi, M Osaki, S Sone, S Imai, S Chiba.   

Abstract

Interleukin-1beta (IL-1beta) production in response to respiratory syncytial virus (RSV) was investigated in normal neonate monocytes. Intracellular or culture supernatant IL-1beta protein levels were measured by enzyme immunoassay. The expression of mRNAs for interferon regulatory factor 1 (IRF-1), IL-1beta-converting enzyme (ICE), and IL-1beta in the cells was analyzed semiquantitatively by reverse transcriptase-PCR. Before RSV exposure, some IRF-1, ICE, and IL-1beta transcripts were already expressed in the monocytes. The levels of these transcripts increased significantly 2 h after RSV exposure compared with those in mock-infected cells. At that time, significantly higher intracellular IL-1beta protein levels were observed in RSV-exposed cells. After 20 h of RSV exposure, quantities of soluble IL-1beta secreted from RSV-exposed cells were moderately higher than those from noninfected cells. These observations suggest that RSV infection of neonatal monocytes triggers enhanced transcription and increased translation of the IL-1beta gene and increased secretion of the soluble protein. The later phase of these processes may be promoted by ICE activity, which was upregulated by increased IRF-1. The increase in IRF-1 activity may also result from RSV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420296      PMCID: PMC109445     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Induction of histidine and ornithine decarboxylase activities in mouse tissues by recombinant interleukin-1 and tumor necrosis factor.

Authors:  Y Endo
Journal:  Biochem Pharmacol       Date:  1989-04-15       Impact factor: 5.858

2.  Sequence of a cDNA coding for human IRF-1.

Authors:  M Maruyama; T Fujita; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

3.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

4.  Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide.

Authors:  R C Fuhlbrigge; D D Chaplin; J M Kiely; E R Unanue
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection.

Authors:  L S Richardson; R H Yolken; R B Belshe; E Camargo; H W Kim; R M Chanock
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

6.  Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.

Authors:  F D Martinez; W J Morgan; A L Wright; C J Holberg; L M Taussig
Journal:  N Engl J Med       Date:  1988-10-27       Impact factor: 91.245

7.  Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection.

Authors:  B R Murphy; D W Alling; M H Snyder; E E Walsh; G A Prince; R M Chanock; V G Hemming; W J Rodriguez; H W Kim; B S Graham
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

8.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.

Authors:  M Miyamoto; T Fujita; Y Kimura; M Maruyama; H Harada; Y Sudo; T Miyata; T Taniguchi
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

9.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.

Authors:  S Haskill; C Johnson; D Eierman; S Becker; K Warren
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

10.  Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.

Authors:  N J Roberts; A H Prill; T N Mann
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  13 in total

1.  Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-converting enzyme gene expression but does not cause apoptosis.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; K Haseyama; N Mizue; S Chiba
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection.

Authors:  L H Thomas; M I Wickremasinghe; M Sharland; J S Friedland
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Respiratory syncytial virus activates Rab5a to suppress IRF1-dependent IFN-λ production, subverting the antiviral defense of airway epithelial cells.

Authors:  Shi Mo; Wei Tang; Jun Xie; Sisi Chen; Luo Ren; Na Zang; Xiaohong Xie; Yu Deng; Leiqiong Gao; Enmei Liu
Journal:  J Virol       Date:  2021-01-27       Impact factor: 6.549

4.  Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D3.

Authors:  Randy E Sacco; Brian J Nonnecke; Mitchell V Palmer; W Ray Waters; John D Lippolis; Timothy A Reinhardt
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

5.  The Anti-Apoptotic Effect of Respiratory Syncytial Virus on Human Peripheral Blood Neutrophils is Mediated by a Monocyte Derived Soluble Factor.

Authors:  Christopher M Coleman; Karen Plant; Susan Newton; Lynsey Hobson; Moira K B Whyte; Mark L Everard
Journal:  Open Virol J       Date:  2011-10-18

6.  Caspase-1 independent viral clearance and adaptive immunity against mucosal respiratory syncytial virus infection.

Authors:  Ye Ri Shim; Heung Kyu Lee
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

Review 7.  Modulation of host adaptive immunity by hRSV proteins.

Authors:  Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Claudia A Riedel; Susan M Bueno; Alexis M Kalergis
Journal:  Virulence       Date:  2014       Impact factor: 5.882

Review 8.  New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.

Authors:  Nicolás M S Gálvez; Jorge A Soto; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

9.  Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections.

Authors:  Deepthi Kolli; Thangam Sudha Velayutham; Antonella Casola
Journal:  Pathogens       Date:  2013-06-01

10.  Siglec-1 inhibits RSV-induced interferon gamma production by adult T cells in contrast to newborn T cells.

Authors:  Jop Jans; Wendy W J Unger; Marloes Vissers; Inge M L Ahout; Inge Schreurs; Arthur Wickenhagen; Ronald de Groot; Marien I de Jonge; Gerben Ferwerda
Journal:  Eur J Immunol       Date:  2018-01-18       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.